Results 221 to 230 of about 266,598 (267)
Some of the next articles are maybe not open access.
Apoptosis in rheumatic diseases
The American Journal of Medicine, 2000Apoptosis, or programmed cell death (PCD), is a form of cellular demise that occurs when cells are damaged or no longer needed. It plays an important role in embryogenesis, normal tissue homeostasis, as well as in certain pathologic conditions, such as in oncogenesis, acquired immunodeficiency syndrome (AIDS), certain neurodegenerative diseases, and in
T, Grodzicky, K B, Elkon
openaire +2 more sources
Annals of the New York Academy of Sciences, 2010
Opioids are the most potent analgesics available and are well established for the treatment of severe acute, surgical, and cancer pain. However, their use to ameliorate chronic noncancer pain (CNCP) is still controversial because of the side effects, such as tolerance, somnolence, confusion, constipation, addiction, withdrawal, and anxiety about ...
L J, Lang +3 more
openaire +2 more sources
Opioids are the most potent analgesics available and are well established for the treatment of severe acute, surgical, and cancer pain. However, their use to ameliorate chronic noncancer pain (CNCP) is still controversial because of the side effects, such as tolerance, somnolence, confusion, constipation, addiction, withdrawal, and anxiety about ...
L J, Lang +3 more
openaire +2 more sources
PROSTAGLANDINS IN THE RHEUMATIC DISEASES*
Annals of the New York Academy of Sciences, 1975The prostaglandins may participate in the pathogenesis of the inflammatory rheumatic diseases by acting as mediators of inflammation and in promoting bone resorption. Levels of PGB (presumed to arise from PGE) in synovial fluids are elevated in the majority of a group of patients with inflammatory rheumatic diseases, as compared to similar patients ...
D R, Robinson, M B, McGuire, L, Levine
openaire +2 more sources
Cryotherapy in rheumatic diseases
Joint Bone Spine, 2012Joint Bone Spine - In Press.Proof corrected by the author Available online since samedi 26 novembre ...
Demoulin, Christophe +1 more
openaire +3 more sources
Acute Rheumatism and Rheumatic Heart Disease
Journal of the Royal Sanitary Institute, 1951Although there has been a substantial decline in its prevalence during the last twenty years, acute rheumatism remains one of the most important diseases of the rheumatic group. Infection with hæmolytic streptococci of Group A is at present the only factor in the aetiology of acute rheumatism which can be identified with confidence.
openaire +2 more sources
The Lancet, 2012
Rheumatic heart disease, often neglected by media and policy makers, is a major burden in developing countries where it causes most of the cardiovascular morbidity and mortality in young people, leading to about 250,000 deaths per year worldwide.
Eloi, Marijon +3 more
openaire +2 more sources
Rheumatic heart disease, often neglected by media and policy makers, is a major burden in developing countries where it causes most of the cardiovascular morbidity and mortality in young people, leading to about 250,000 deaths per year worldwide.
Eloi, Marijon +3 more
openaire +2 more sources
Current Opinion in Cardiology, 1996
Rheumatic heart disease seems in many ways emblematic of an older era in medicine, without any prospects of new development or change in the current era. Many new findings have come to light in the past few years regarding this illness, which has a relatively low prevalence in the United States.
openaire +2 more sources
Rheumatic heart disease seems in many ways emblematic of an older era in medicine, without any prospects of new development or change in the current era. Many new findings have come to light in the past few years regarding this illness, which has a relatively low prevalence in the United States.
openaire +2 more sources
Scintigraphy in rheumatic diseases
Best Practice & Research Clinical Rheumatology, 2004The aim of this review is to summarise the clinical role of nuclear medicine in rheumatology taking into consideration the most specific diagnostic applications and other worthwhile therapeutic contributions. Traditional bone scintigraphy and recent inflammation-targeting radiopharmaceuticals, such as radiolabelled leucocytes and immunoscintigraphy ...
COLAMUSSI P. +4 more
openaire +2 more sources
The liver in rheumatic diseases
Seminars in Arthritis and Rheumatism, 1982HE HEPATIC manifestations of the rheumatic diseases are not well described. The frequency, significance, and the specific hepatic pathology varies with each rheumatic illness. Abnormalities of liver tests in this setting may lead to diagnostic confusion and the need for extensive evaluation.
M E, Weinblatt +2 more
openaire +2 more sources
Epidemiology of the rheumatic diseases
Current Opinion in Rheumatology, 1994Understanding, description, and classification of musculoskeletal pain syndromes have been further substantiated, but linking them to physical and psychological variables remains problematic. Core tools to measure disability in a population context forms a stable, well validated set of instruments, which increasingly has been translated, tested, and ...
openaire +2 more sources